References
Liu C, Liu L (2011) Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis. Tumour Biol 32:1233–1240
Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2010) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat 121:703–708
Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC (2010) MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat 123:549–555
Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM (2010) Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122:251–257
Li X, Hu Z, Qu X, Zhu J, Li L, Ring BZ, Su L (2011) Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis. PLoS ONE 6:e14749
Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, Li D, Parl FF, Rylander-Rudqvist T, Soucek P, Zheng W, Wedren S, Taioli E (2007) Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol 165:115–125
Liu X, Wang Z, Yu J, Lei G, Wang S (2010) Three polymorphisms in interleukin-1β gene and risk for breast cancer: a meta-analysis. Breast Cancer Res Treat 124:821–825
Sergentanis TN, Economopoulos KP (2010) Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 120:229–234
Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P (2007) Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63:125–149
Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Yu L (2010) The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122:879–882
Francisco G, Menezes PR, Eluf-Neto J, Chammas R (2008) XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 16:724–734
Hu J, Zhou GW, Wang N, Wang YJ (2010) GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124:425–431
Xi B, Zeng T, Liu L, Liang Y, Liu W, Hu Y, Li J (2011) Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 130:561–568
Wang N, Zhou R, Wang C, Guo X, Chen Z, Yang S, Li Y (2012) 251 T/A polymorphism of the interleukin-8 gene and cancer risk: a huge review and meta-analysis based on 42 case-control studies. Mol Biol Rep 39:2831–2841
Xu W, Li Y, Wang X, Chen B, Wang Y, Liu S, Xu J, Zhao W, Wu J (2010) FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects. Eur J Cancer 46:3332–3338
Zhou P, Li JP, Zhang C (2011) Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: appraisal of a recent meta-analysis. Breast Cancer Res Treat 126:253–256
Qiu LX, Zhang J, Zhu XD, Zheng CL, Sun S, Wang ZH, Zhao XM, Wang JL, Wang LP, Yu H, Xue K, Hu XC (2010) The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects. Breast Cancer Res Treat 124:475–479
Li N, Dong J, Hu Z, Shen H, Dai M (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:177–184
Kirchhoff T, Chen ZQ, Gold B, Pal P, Gaudet MM, Kosarin K, Levine DA, Gregersen P, Spencer S, Harlan M, Robson M, Klein RJ, Hudis CA, Norton L, Dean M, Offit K (2009) The 6q22.33 locus and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 18:2468–2475
Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, Wang X, Shen H, Hu Z (2009) Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk—A meta-analysis. Eur J Cancer 45:2874–2881
Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2010) IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Breast Cancer Res Treat 122:867–871
Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen W, Chen MB (2011) Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 125:537–543
Saadat M (2012) Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Epidemiol 36:e101–e103
Zintzaras E, Grammatikou M, Kitsios GD, Doxani C, Zdoukopoulos N, Papandreou C, Patrikidou A (2010) Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association study and meta-analysis. J Hum Genet 55:743–748
Hao Y, Montiel R, Huang Y (2010) Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124:809–813
Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC (2010) NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 123:877–883
Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E (2009) Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat 117:151–159
Liao RY, Mao C, Qiu LX, Ding H, Chen Q, Pan HF (2010) TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Mol Biol Rep 37:3227–3232
Wang J, Bi J, Liu X, Li K, Di J, Wang B (2012) Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol Biol Rep 39:4571–4579
Shen W, Cao X, Xi L, Deng L (2012) CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 39:2039–2044
Zhang Z, Xue H, Gong W, Wang M, Yuan L, Han S, Zhang Z (2009) FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies. Carcinogenesis 30:487–493
Ye Z, Parry JM (2002) The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17:119–126
Jia C, Cai Y, Ma Y, Fu D (2010) Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. Breast Cancer Res Treat 124:521–528
Weston A, Godbold JH (1997) Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Perspect 4:919–926
Zhang C, Lv GQ, Yu XM, Gu YL, Li JP, Du LF, Zhou P (2011) Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 128:467–472
Sergentanis TN, Economopoulos KP (2011) Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep 38:4955–4963
Lu S, Wang Z, Cui D, Liu H, Hao X (2011) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects. Breast Cancer Res Treat 125:253–259
Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G (2008) Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Res Treat 109:91–99
Mao C, Chung VC, He BF, Luo RC, Tang JL (2012) Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 39:1113–1118
Raimondi S, Johansson H, Maisonneuve P, Gandini S (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30:1170–1180
Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, Wang JL, Wang BY, Lv FF, Wu XH, Hu LQ (2011) miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine 56:589–592
Zhao E, Cui D, Yuan L, Lu W (2012) MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 39:3471–3477
Zhou GW, Hu J, Peng XD, Li Q (2011) RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125:529–535
Yu KD, Rao NY, Chen AX, Fan L, Yang C, Shao ZM (2011) A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast Cancer Res Treat 126:37–45
Zhao T, Lv J, Zhao J, Nzekebaloudou M (2009) Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis. J Exp Clin Cancer Res 28:159
He XF, Wei W, Su J, Yang ZX, Liu Y, Zhang Y, Ding DP, Wang W (2012) Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies. Mol Biol Rep 39:5125–5134
Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, Wei YG, Tang M, Zhang L (2011) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat 125:827–835
Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122:459–469
Ding DP, He XF, Zhang Y (2011) Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast Cancer Res Treat 129:203–209
Jiang Y, Zhou L, Yan T, Shen Z, Shao Z, Lu J (2010) Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue. J Exp Clin Cancer Res 29:101
Zhou P, Du LF, Lv GQ, Yu XM, Gu YL, Li JP, Zhang C (2011) Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 127:813–818
Yuan W, Xu L, Chen W, Wang L, Fu Z, Pang D, Li D (2011) Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 125:467–472
Hu Z, Li X, Qu X, He Y, Ring BZ, Song E, Su L (2010) Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis 31:643–647
Yao L, Cao LH, Qiu LX, Yu L (2010) The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects. Breast Cancer Res Treat 123:577–580
Lu S, Wang Z, Liu H, Hao X (2010) HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies. Breast Cancer Res Treat 124:771–778
Wang J, Wang B, Bi J, Di J (2011) The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 128:203–209
Ma X, Chen C, Xiong H, Li Y (2010) Transforming growth factorβ1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls. Breast Cancer Res Treat 124:453–457
Saadat M, Ansari-Lari M (2009) Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 115:137–144
Huang Y, Li L, Yu L (2009) XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24:331–339
Saadat M (2010) Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 124:785–791
Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC (2010) XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast Cancer Res Treat 124:229–235
Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Hu XC, Yu L (2010) The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects. Breast Cancer Res Treat 123:227–231
García-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing JP (2006) Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 19:376–388
Saadat M (2012) Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Res Treat 44:121–126
Sun H, Bai J, Chen F, Jin Y, Yu Y, Fu S (2011) Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects. Breast Cancer Res Treat 125:175–179
Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725
Sergentanis TN, Economopoulos KP (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:195–202
Liu C, Wang Y, Wang QS, Wang YJ (2012) The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev 13:1355–1360
Xu L, Ju XB, Li P, Wang J, Shi ZM, Zheng MJ, Xue DD, Xu YJ, Yin YM, Wang S, You YP (2012) Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysis. Asian Pac J Cancer Prev 13:683–687
Saccone S, De Sario A, Della Valle G, Bernardi G (1992) The highest gene concentrations in the human genome are in T-bands of metaphase chromosomes. Proc Natl Acad Sci USA 89:4913–4917
Saccone S, Caccio S, Kusuda J, Andreozzi L, Bernardi G (1996) Identification of the generichest bands in human chromosomes. Gene 174:85–94
Mouchiroud D, D’Onofrio G, Aissani B, Macaya G, Gautier C, Bernardi G (1991) The distribution of genes in the human genome. Gene 100:181–187
Musio A, Mariani T, Vezzoni P, Frattini A (2002) Heterogeneous gene distribution reflects human genome complexity as detected at the cytogenetic level. Cancer Genetics Cytogenet 134:168–171
Rafiee L, Mohsenzadeh S, Saadat M (2008) Nonrandom gene distribution on human chromosomes. EXCLI Journal 7:151–153
Hecht F (1988) Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands. Cancer Genet Cytogenet 31:17–24
Lima-de-Faria A, Mitelman F (1988) The chromosome territory of human oncogenes. Bioscience Rep 6:349–354
Lima-de-Faria A, Mitelman F, Blomberg J, Pfeifer-Ohlsson S (1991) Telomeric location of retroviral oncogenes in humans. Hereditas 114:207–211
Tai JJ, Hou CD, Wang-Wuu S, Wang CH, Leu SY, Wuu KD (1993) A method for testing the nonrandomness of chromosomal breakpoints. Cytogenet Cell Genet 63:147–150
ISCN (1981) An international system for human cytogenetic nomenclature-high resolution banding. Cytogenet Cell Genet 31:1–23
Acknowledgments
The authors are indebted to Dr. Maryam Ansari-Lari for critical reading of the manuscript and for her contribution in discussion. This study was supported by Shiraz University.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saify, K., Saadat, M. Non-random distribution of breast cancer susceptibility loci on human chromosomes. Breast Cancer Res Treat 136, 315–318 (2012). https://doi.org/10.1007/s10549-012-2208-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-012-2208-0